SEE ALSO...
Items 21 to 24 of 24 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(R)-(-)-3-Quinuclidinyl benzilate | 62869-69-6 | sc-264196 | 5 mg | $166.00 | ||
(R)-(-)-3-Quinuclidinyl benzilate exhibits a unique affinity for muscarinic M3 receptors, characterized by its ability to induce allosteric modulation. This compound's steric configuration allows for specific interactions that stabilize receptor conformations, influencing downstream signaling pathways. Its lipophilic nature enhances membrane permeability, facilitating rapid receptor engagement. The compound's kinetic profile reveals a distinct binding mechanism, providing insights into receptor activation dynamics. | ||||||
Aclidinium Bromide | 320345-99-1 | sc-480200 | 100 mg | $388.00 | ||
Aclidinium, a long-acting mAChR M3 antagonist, is studied in the research of COPD. By inhibiting mAChR M3 in the airways, it promotes bronchodilation and helps manage respiratory symptoms associated with COPD, such as shortness of breath and coughing. | ||||||
Tropicamide | 1508-75-4 | sc-202371 | 100 mg | $32.00 | 3 | |
Tropicamide, a muscarinic receptor antagonist, inhibits mAChR M3 in the eye. By inducing pupil dilation and preventing accommodation during eye examinations, it serves as a mydriatic and cycloplegic agent. Its inhibition of mAChR M3 contributes to the desired ocular effects. | ||||||
L-Hyoscyamine | 101-31-5 | sc-295290 sc-295290A | 1 g 5 g | $222.00 $408.00 | ||
Hyoscyamine, a tropane alkaloid, acts as a mAChR M3 antagonist, exerting antispasmodic effects in smooth muscles. Its inhibition of muscarinic receptors helps alleviate symptoms of gastrointestinal disorders, such as irritable bowel syndrome (IBS), by reducing smooth muscle contractions and promoting relaxation. | ||||||